按糖尿病状态解析非ST段抬高型心肌梗死患者长期死亡风险的差异:一项全国性队列研究
基于英国MINAP登记库2005年1月至2019年3月住院的456,376例非ST段抬高型心肌梗死成人,按糖尿病状态比较结局与照护质量。糖尿病患者30天、1年、5年、10年死亡风险均高于无糖尿病者(HR 1.19至1.39)。在糖尿病患者中,住院照护质量越高,死亡风险越低。
要点
- 糖尿病患者30天死亡风险高于无糖尿病者(HR 1.19,95%CI 1.15,1.23)
- 糖尿病患者10年死亡风险高于无糖尿病者(HR 1.39,95%CI 1.36,1.42)
- 糖尿病患者中住院照护质量为优者死亡风险低于照护差者(HR 0.69,95%CI 0.68,0.71)
核心结论
- 糖尿病患者在NSTEMI住院期间照护存在差异,其长期死亡风险高于无糖尿病者,更高质量的住院照护可能与更好的长期生存相关。
研究设计与样本
- 分析英国心肌缺血国家审计项目(MINAP)登记库中2005年1月至2019年3月住院的456,376例NSTEMI成人,并与国家统计局死亡报告链接,按糖尿病状态比较结局与照护质量。
主要发现
- 糖尿病患者较无糖尿病者年龄更大(中位年龄74 vs 73岁),亚裔比例更高(13% vs 4%),接受血运重建(经皮冠状动脉介入治疗或冠状动脉旁路移植术)更少(38% vs 40%)。
- 糖尿病患者相比无糖尿病者死亡风险在30天(HR 1.19,95%CI 1.15,1.23)、1年(HR 1.28,95%CI 1.26,1.31)、5年(HR 1.36,95%CI 1.34,1.38)、10年(HR 1.39,95%CI 1.36,1.42)均更高。
- 在糖尿病患者中,以机会性质量指标(OBQI)评分分类评估,较高住院照护质量相比差照护与更低死亡率相关(良:HR 0.74,95%CI 0.73,0.76;优:HR 0.69,95%CI 0.68,0.71)。
- 在糖尿病患者中,相比差照护,优级照护在饮食治疗亚组(HR 0.64,95%CI 0.61,0.68)与胰岛素治疗亚组(HR 0.69,CI 0.66,0.72)与最低死亡率相关。
关键数值与推荐
- 死亡风险比较:糖尿病患者 vs 无糖尿病者,30天 HR 1.19(95%CI 1.15,1.23)、1年 HR 1.28(95%CI 1.26,1.31)、5年 HR 1.36(95%CI 1.34,1.38)、10年 HR 1.39(95%CI 1.36,1.42)。
- 照护质量比较(糖尿病患者,以差照护为参照):良 HR 0.74(95%CI 0.73,0.76),优 HR 0.69(95%CI 0.68,0.71)。
- 亚组比较(糖尿病患者,以差照护为参照):饮食治疗亚组优级照护 HR 0.64(95%CI 0.61,0.68),胰岛素治疗亚组优级照护 HR 0.69(CI 0.66,0.72)。
临床怎么用
- 作者认为,糖尿病患者NSTEMI住院期间照护存在差异,更高质量的住院照护可能带来更好的长期生存。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to investigate how diabetes mellitus affects longer term outcomes in individuals presenting to hospital with non-ST segment elevation myocardial infarction (NSTEMI). METHODS: We analysed data from 456,376 adults hospitalised between January 2005 and March 2019 with NSTEMI from the UK Myocardial Ischaemia National Audit Project (MINAP) registry, linked with Office for National Statistics death reporting. We compared outcomes and quality of care by diabetes status. RESULTS: Individuals with diabetes were older (median age 74 vs 73 years), were more often of Asian ethnicity (13% vs 4%) and underwent revascularisation (percutaneous coronary intervention or coronary artery bypass graft surgery) (38% vs 40%) less frequently than those without diabetes. The mortality risk for those with diabetes compared with those without was significantly higher at 30 days (HR 1.19, 95% CI 1.15, 1.23), 1 year (HR 1.28, 95% CI 1.26, 1.31), 5 years (HR 1.36, 95% CI 1.34, 1.38) and 10 years (HR 1.39, 95% CI 1.36, 1.42). In individuals with diabetes, higher quality inpatient care, assessed by opportunity-based quality indicator (OBQI) score category ('poor', 'fair', 'good' or 'excellent'), was associated with lower mortality rates compared with poor care (good: HR 0.74, 95% CI 0.73, 0.76; excellent: HR 0.69, 95% CI 0.68, 0.71). In addition, compared with poor care, excellent care in the diabetes group was associated with the lowest mortality rates in the diet-treated and insulin-treated subgroups (diet-treated: HR 0.64, 95% CI 0.61, 0.68; insulin-treated: HR 0.69, CI 0.66, 0.72). CONCLUSION/INTERPRETATION: Individuals with diabetes experience disparities during inpatient care following NSTEMI. They have a higher risk of long-term mortality than those without diabetes, and higher quality inpatient care may lead to better long-term survival.
引用
- Cole A, Weight N, Misra S, et al. Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study. Diabetologia. 2024. PMID: 39358593. doi:10.1007/s00125-024-06281-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。